Evidence map›Paper›PMID 34281277›Full record

ArticleInternational journal of molecular sciences2021

Agnieszka Szmyt, Agnieszka Zabłocka, Józefa Macała, Józefa Chrzanowska, Anna Dąbrowska

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Agnieszka SzmytDepartment of Functional Food Products Development, Wroclaw University of Environmental and Life Science, 37 Chełmońskiego Str., 51-640 Wrocław, Poland.
Agnieszka ZabłockaDepartment of Microbiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Science, 12 Rudolf Weigl Str., 53-114 Wrocław, Poland.ORCID 0000-0002-5707-9886
Józefa MacałaDepartment of Microbiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Science, 12 Rudolf Weigl Str., 53-114 Wrocław, Poland.
Józefa ChrzanowskaDepartment of Functional Food Products Development, Wroclaw University of Environmental and Life Science, 37 Chełmońskiego Str., 51-640 Wrocław, Poland.ORCID 0000-0002-9410-5297
Anna DąbrowskaDepartment of Functional Food Products Development, Wroclaw University of Environmental and Life Science, 37 Chełmońskiego Str., 51-640 Wrocław, Poland.ORCID 0000-0002-8524-5802
Wrocław University of Environmental and Life Sciences · PLLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this research was to analyze the heterologous expression, purification, and immunoregulatory activity of recombinant YGP40 (rYGP40), the potential precursor of the yolkin peptide complex. The ygp40 coding sequence was codon optimized, successfully expressed in the

Indexed as

AnimalsCell SurvivalChickensCloning, MolecularEgg YolkFemaleHumansImmunologic FactorsInterleukin-10In Vitro TechniquesMacrophagesMiceMolecular WeightNitric OxideNitric Oxide Synthase Type IIPeptide FragmentsImmunologic FactorsInterleukin-10Nitric OxideNitric Oxide Synthase Type IINos2 protein, mousePeptide FragmentsRecombinant ProteinsTumor Necrosis Factor-alphaVitellogeninsimmunoregulatory activityvitellogeninYGP40yolkin polypeptide complex

Identifiers

PMID34281277
PMCPMC8268165
OpenAlexW3180458508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.